Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-04
2005-10-04
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S503000, C548S312100, C548S444000, C514S411000, C514S397000
Reexamination Certificate
active
06951881
ABSTRACT:
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a disorder relating to or affected by the 5-HT6 receptor.
REFERENCES:
patent: 0505322 (1992-09-01), None
patent: WO 94/14771 (1994-07-01), None
patent: WO 200212178 (2002-02-01), None
Sleight et al. Annals of New York Academy of Sciences, 861:91-96, 1998.
Buchheit, Karl-Heinz et al.,Journal of Medicinal Chemistry, 1995, 38:2326-2330.
Buchheit, Karl-Heinz et al.,Journal of Medicinal Chemistry, 1995, 38:2331-2338.
Buchheit, Karl-Heinz et al.,Bioorganic&Medicinal Chemistry Letters, 1995, 5(21):2495-2500.
Nguyen, Adrienne et al.,The Journal of Pharmacology and Experimental Therapeutics, 1997, 280:1270-1276.
Husain, M.I. and Jamali, M.R.,Indian Journal of Chemistry, 1989, 28B:532-534.
Bravo Byron Abel
Cole Derek Cecil
Kelly Michael Gerard
Palmer Yvette Latko
Balasubramanian Venkataraman
Lences Barbara L.
Wyeth
LandOfFree
(1-substituted-indol-3-yl)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (1-substituted-indol-3-yl)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1-substituted-indol-3-yl)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3456557